Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Response to Varicella Zoster Vaccination (ZOSTAVAX) in Subjects With Rheumatoid Arthritis

NCT01506661 is registered in ClinicalTrials.gov with Oklahoma Medical Research Foundation as lead sponsor.

NCT NCT01506661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01506661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Response to Varicella Zoster Vaccination (ZOSTAVAX) in Subjects With Rheumatoid Arthritis
Lead sponsor
Oklahoma Medical Research Foundation
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2012
Completion date
October 31, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis, varicella zoster